Key Considerations for Healthcare Companies Listing on a US Exchange PodcastBack Bay Life Science AdvisorsMay 23, 2024IPO, Healthcare, M&A
The Latest in Healthcare Trends and Transactions NewsletterBack Bay Life Science AdvisorsNovember 14, 2023Renal, Cardiovascular, IPO
Inefficient Markets: Public Market Dislocations and Negative Biotech Enterprise Values BlogInvestment Banking TeamMay 31, 2022BioPharma, IPO, Investing
Biopharma Companies Don’t Need to Be Public to Survive BlogInvestment Banking TeamApril 14, 2022BioPharma, IPO, Investing